glutathione mutations in sclc patients Cell Death, Molecular Targeted Therapies, and Metabolic Reprogramming EGFR-Mutant Lung Cancer The Era of Antibody Drug
The Era of Antibody Drug Conjugates in Lung Cancer: Trick or Threat? Oncology Letters Inhibiting the system xC glutathione axis selectively targets cancers with mutant p53 accumulation Nature Communications In vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer Science Advances Impact of the deletion glutathione S transferase (class Mu) on lung cancer risk among smokers The Egyptian Journal of Bronchology Springer Nature Link
Pay in 4 interest-free payments of $7.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3



